Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07030686 · ClinicalTrials.gov registry record
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
A clinical trial of Cancer and Survivorship, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 4
- Study locations
NCT07030686: Recruiting study of Cancer and Survivorship, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07030686 is a study of Cancer and Survivorship that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,000 participants, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (71% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07030686, a study of Cancer and Survivorship, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.
Primary Outcome
To estimate the association of exercise vs. usual care (control) with Distant disease-free survival (DDFS) among patients following the completion of active treatment for the primary index cancer being monitored at MSK.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (4)
California
- City of Hope Cancer Center (Data Analysis Only) - Duarte
- University of California, Los Angeles (Data or Specimen Analysis Only) - Los Angeles
New York
- Weill Cornell Medical College (Data or Specimen Analysis Only) - New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-03-19 |
| Est. Completion | 2026-03-19 |
What NCT07030686 shows while recruiting
NCT07030686 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (71% lower).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT07030686 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT07030686 about?
NCT07030686 is a clinical study titled "Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors". This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.
What is the current status of trial NCT07030686?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-03-19. Estimated completion is 2026-03-19.
What conditions does trial NCT07030686 study?
This clinical trial studies the following conditions: Cancer, Survivorship, Recurrence, Recurrent, Remission.
What interventions are being tested in trial NCT07030686?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07030686?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07030686 being conducted?
This trial has 4 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07030686's enrollment target sits among peer trials
1,000 80th of 615 higher than 531 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI